Fig. 1From: Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumabScatterplots of BCVA and OCT metrics at baseline and follow-up in the entire study cohort. The cohort included 52 eyes. A Best-corrected visual acuity. B Central subfield thickness. C Total macular volume. Blue and orange horizontal lines indicate mean and standard deviation. P-values were derived from paired Student’s t-tests and Wilcoxon signed rank tests. Significant at p < 0.05Back to article page